UM Miller School of Medicine: Access to Targeted Lung Cancer Drug is Cost-Prohibitive
May 31, 2024
May 31, 2024
MIAMI, Florida, May 31 (TNSres) -- The University of Miami's Miller School of Medicine issued the following news:
By Charlotte Schubert
Access to new, targeted drugs is often limited by the ability of national health care systems and insurance companies to pay.
Many countries use cost-effectiveness analyses to decide whether to cover new medicines. Such research balances the costs of treatment with positive effects on health.
A new study examin . . .
By Charlotte Schubert
Access to new, targeted drugs is often limited by the ability of national health care systems and insurance companies to pay.
Many countries use cost-effectiveness analyses to decide whether to cover new medicines. Such research balances the costs of treatment with positive effects on health.
A new study examin . . .